Posts Tagged ‘biond’

Israel’s Biond Biologics to get $125 million from Sanofi to develop cancer drug

Israeli cancer immunotherapy firm startup Biond Biologics said Tuesday it has entered an exclusive worldwide license agreement with Paris-based multinational pharma firm Sanofi for the development and commercialization of its flagship anti-tumor drug BND-22. Under the terms of the agreement, Biond will get an upfront payment of $125 million in cash and could get $1 […]

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes